Feasible Fabrication of Chitosan Capped Mesoporous Silica Nanoparticles as a Smart Mucoadhesive Drug Delivery Platform for Dexamethasone for Long Term Lung Treatment — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Feasible Fabrication of Chitosan Capped Mesoporous Silica Nanoparticles as a Smart Mucoadhesive Drug Delivery Platform for Dexamethasone for Long Term Lung Treatment
Viterbi School of Chemical Engineering, University of Southern California, Los Angeles, CA
,
Molecular Science and Technology Program, Taiwan International Graduate Program (TIGP), Academia Sinica, Taipei City
,
Department of Chemical Engineering, NTU, Taipei City
,
International Graduate Program of Molecular Science and Technology (NTU-MST), NTU, Taipei City
1 Viterbi School of Chemical Engineering, University of Southern California, Los Angeles, CA
2 Molecular Science and Technology Program, Taiwan International Graduate Program (TIGP), Academia Sinica, Taipei City
3 Department of Chemical Engineering, NTU, Taipei City
4 International Graduate Program of Molecular Science and Technology (NTU-MST), NTU, Taipei City
Among the carriers, mesoporous silica nanoparticles (MSN) were promising for drug carriers due to their biocompatibility and high porosity, thereby increasing the loading of therapeutic agents. Chitosan, a biocompatible polymer with a positive charge, was used to modify the MSN surface in order to achieve strong electrostatic mucoadhesion and further improve drug loading capacity and sustainable release profile. The MCM-41 type was prepared using a CTAB-templated sol-gel method. The SBA-15 type MSNs were prepared using the P123 surfactant template. MCM-41 was further aminated, then coated with chitosan via the crosslinking of glutaraldehyde. With an X-ray diffractometer, the hexagonal close-packed crystal structure of MSN was verified for MCM-41 and SBA-15. SEM demonstrated the particle morphology and distribution of MSNs. Fourier transform infrared spectroscopy measured vibration modes of alkyl, amine, hydroxyl, and silica functions, confirming the encapsulation of chitosan on the MCM-41 (MCM-41-CHIT) surface. The small dexamethasone was encapsulated in the chitosan capped MCM-41. The drug loading capacity of MCM-41-CHIT revealed 53.7%. The burst release of dexamethasone in the unmodified MSNs was noted, which showed 80% in 24 hours. On the other hand, drug release in MCM-41-CHIT showed constant and delayed release, which showed only 19.7% in 120 hours and a potential to last 55 days. In summary, this research established chitosan capped MCM-41 as a potentially efficient candidate for the mucoadhesive drug delivery system used in long-term treatment.
WHO (2025) Coronavirus Disease (COVID-19). https://www.who.int/health-topics/coronavirus
Recovery Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., et al . (2021) Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine , 384, 693-704. https://doi.org/10.1056/nejmoa2021436
Li, A.F.Y., Wang, C.L., Tai, H.Y., Fu, Y.J., Tsai, F.T., Tsai, Y.C., et al . (2021) Pandemic Aspect of Dexamethasone: Molecular Mechanisms and Clinical Application. Journal of the Chinese Medical Association , 84, 245-247. https://doi.org/10.1097/jcma.0000000000000485
Johnson, D.B., Lopez, M.J. and Kelley, B. (2025) Dexamethasone. StatPearls Publishing.
Vardy, J., Chiew, K.S., Galica, J., Pond, G.R. and Tannock, I.F. (2006) Side Effects Associated with the Use of Dexamethasone for Prophylaxis of Delayed Emesis after Moderately Emetogenic Chemotherapy. British Journal of Cancer , 94, 1011-1015. https://doi.org/10.1038/sj.bjc.6603048
Polderman, J.A., Farhang-Razi, V., Van Dieren, S., Kranke, P., DeVries, J.H., Hollmann, M.W., et al . (2018) Adverse Side Effects of Dexamethasone in Surgical Patients. Cochrane Database of Systematic Reviews , 11, CD011940. https://doi.org/10.1002/14651858.cd011940.pub3
Amin, M.K. and Boateng, J.S. (2022) Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery. Marine Drugs , 20, Article 156. https://doi.org/10.3390/md20030156
Vaezi Moghaddam, A., Mortazavi, S.A., Kobarfard, F., Bafkary, R. and Darbasizadeh, B. (2023) Synthesis and Functionalization of Mucoadhesive Mesoporous Silica Particles Containing Diphenhydramine for Treatment of Aphthous Ulcers. BioImpacts , 13, 456-466. https://doi.org/10.34172/bi.2023.27548
Sharma, R., Kumar, S., Malviya, R., Prajapati, B.G., Puri, D., Limmatvapirat, S., et al . (2024) Recent Advances in Biopolymer-Based Mucoadhesive Drug Delivery Systems for Oral Application. Journal of Drug Delivery Science and Technology , 91, Article 105227. https://doi.org/10.1016/j.jddst.2023.105227
Harris, D. and Robinson, J.R. (1992) Drug Delivery via the Mucous Membranes of the Oral Cavity. Journal of Pharmaceutical Sciences , 81, 1-10. https://doi.org/10.1002/jps.2600810102
Dobbs, E.C. (1963) Drugs Which Act on the Skin and Mucous Membranes. Dental Clinics of North America , 7, 473-487. https://doi.org/10.1016/s0011-8532(22)02061-4
Sato, H. (2025) Development of Nanoparticle-Based Mucosal Drug Delivery Systems for Controlling Pharmacokinetic Behaviors. Biological and Pharmaceutical Bulletin , 48, 759-768. https://doi.org/10.1248/bpb.b25-00071
Yan, X. and Sha, X. (2023) Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa. Pharmaceutics , 15, Article 2457. https://doi.org/10.3390/pharmaceutics15102457
Zheng, B., Liu, D., Qin, X., Zhang, D. and Zhang, P. (2025) Mucoadhesive-to-Mucopenetrating Nanoparticles for Mucosal Drug Delivery: A Mini Review. International Journal of Nanomedicine , 20, 2241-2252. https://doi.org/10.2147/ijn.s505427
Kankala, R.K., Han, Y., Na, J., Lee, C., Sun, Z., Wang, S., et al . (2020) Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles. Advanced Materials , 32, Article 1907035. https://doi.org/10.1002/adma.201907035
Pongchaikul, P., Hajidariyor, T., Khetlai, N., Yu, Y., Arjfuk, P., Khemthong, P., et al . (2023) Nanostructured N/S Doped Carbon Dots/Mesoporous Silica Nanoparticles and PVA Composite Hydrogel Fabrication for Anti-Microbial and Anti-Biofilm Application. International Journal of Pharmaceutics : X , 6, Article 100209. https://doi.org/10.1016/j.ijpx.2023.100209
Gómez, L., Rivero-Buceta, E.M., Vidaurre-Agut, C. and Botella, P. (2025) Preparation of Mesoporous Silica Nanoparticles by Spray Drying. Microporous and Mesoporous Materials , 393, Article 113646. https://doi.org/10.1016/j.micromeso.2025.113646
Ways, T.M.M., Lau, W. and Khutoryanskiy, V. (2018) Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. Polymers , 10, Article 267. https://doi.org/10.3390/polym10030267
Ahmad, K., Zhang, Y., Chen, P., Yang, X. and Hou, H. (2024) Chitosan Interaction with Stomach Mucin Layer to Enhances Gastric Retention and Mucoadhesive Properties. Carbohydrate Polymers , 333, Article 121926. https://doi.org/10.1016/j.carbpol.2024.121926
Zhang, Y., Huo, M., Zhou, J., Zou, A., Li, W., Yao, C., et al . (2010) Ddsolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles. The AAPS Journal , 12, 263-271. https://doi.org/10.1208/s12248-010-9185-1
Albayati, T.M., Salih, I.K. and Alazzawi, H.F. (2019) Synthesis and Characterization of a Modified Surface of SBA-15 Mesoporous Silica for a Chloramphenicol Drug Delivery System. Heliyon , 5, e02539. https://doi.org/10.1016/j.heliyon.2019.e02539
Thahir, R.W., Wahab, A.L., Nafie, N. and Raya, I. (2019) Synthesis of Mesoporous Silica SBA-15 through Surfactant Set-Up and Hydrothermal Process. Rasayan Journal of Chemistry , 12, 1117-1126.
Larki, A., Saghanezhad, S.J. and Ghomi, M. (2021) Recent Advances of Functionalized SBA-15 in the Separation/Preconcentration of Various Analytes: A Review. Microchemical Journal , 169, Article 106601. https://doi.org/10.1016/j.microc.2021.106601
Dabija, M.G., Olaru, I., Ciuhodaru, T., Stefanache, A., Mihai, C., Lungu, I.I., et al . (2025) Chitosan as a Plurivalent Biopolymer in Nanodelivery Systems. Polymers , 17, Article 558. https://doi.org/10.3390/polym17050558
Heredia, N.S., Vizuete, K., Flores-Calero, M., Pazmiño V., K., Pilaquinga, F., Kumar, B., et al . (2022) Comparative Statistical Analysis of the Release Kinetics Models for Nanoprecipitated Drug Delivery Systems Based on Poly (Lactic-Co-Glycolic Acid). PLOS ONE , 17, e0264825. https://doi.org/10.1371/journal.pone.0264825
Dash, S., Murthy, P.N., Nath, L. and Chowdhury, P. (2010) Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems. Acta Poloniae Pharmaceutica , 67, 217-223.